Kallmann: Difference between revisions
CSV import |
CSV import |
||
| Line 24: | Line 24: | ||
{{stub}} | {{stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 16:35, 17 March 2025
Kallmann syndrome is a genetic disorder that prevents a person from starting or fully completing puberty. Kallmann syndrome is a form of a group of conditions termed hypogonadotropic hypogonadism. To distinguish it from other forms of hypogonadotropic hypogonadism, Kallmann syndrome has the additional symptom of a reduced or absent sense of smell (anosmia).
Signs and symptoms[edit]
The primary characteristic of Kallmann syndrome is the failure to start or fully complete puberty. Other symptoms can include a reduced sense of smell, deafness, synkinesis (mirror movements), and cleft lip or palate. The severity of these symptoms can vary widely among those affected.
Causes[edit]
Kallmann syndrome is caused by a disruption in the production of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This disruption is typically due to a genetic mutation, and can be passed down through families.
Diagnosis[edit]
Diagnosis of Kallmann syndrome can be challenging, as the symptoms can be difficult to distinguish from those of other conditions. However, a combination of medical history, physical examination, and laboratory tests can often lead to a diagnosis.
Treatment[edit]
Treatment for Kallmann syndrome typically involves hormone replacement therapy to induce puberty and maintain normal hormone levels. Other treatments may be used to manage additional symptoms.


